EVOLUTION OF ADAPTIVE IMMUNITY
EVOLUTION OF ADAPTIVE IMMUNITY
批准号:
2283255
负责人:
Martin F Flajnik
金额:
$26.13万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-08-01 至 2000-07-31
关键词:
T cell receptor active immunization antibody formation antibody receptor antigen receptors cell type complement pathway cytotoxicity enzyme linked immunosorbent assay evolution gene expression gene mutation immunity immunoglobulin M leukocyte activation /transformation protein structure function sharks
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Immunoglobulin (Ig) and the T cell receptor (TCR) are the only antigen-
specific receptors of the adaptive immune system that have been
extensively characterized. We have discovered a novel antigen receptor in
the nurse shark, Ginglymostoma cirratum, that diverged from the Ig/TCR
line perhaps near the time of the conception of the adaptive immune
system. This molecule, referred to as NAR (novel antigen receptor) is
dimeric in serum and on the cell surface, with each chain being composed
of an N-terminal V domain followed by 5 C domains. The complementarity
determining region 3 (CDR3) of NAR is incredibly diverse in sequence and
length, in part apparently due to "oligonucleotide capture" during the
joining process. There is also a very high frequency of somatic mutation
(up to 12% in cDNA clones that have been analyzed) concentrated in the
CDR. The hypothesis is that NAR is found on the surface of cells in the
shark (and perhaps other vertebrates) that are instrumental in generating
secondary responses, and that such cells may be homologous to "secondary
B cells described in mammalian systems. The study of this molecule (and
its gene) is significant to: l) understand selection pressures on antigen
specific receptors forcing them to adopt particular conformations; 2)
provide a model to examine secondary immune responses; 3) supply, in the
long term, a. novel system to study somatic mutation and "oligonucleotide
capture." NAR will be examined at the cellular, biochemical, molecular,
functional, and phylogenetic levels with existing specific antibodies and
gene probes. The Specific Aims are: 1) to determine which cell types
express NAR and to observe whether other antigen receptors (like IgM or
TCR) are excluded from such cells; 2) to study the biochemical structure
of NAR, concentrating on associated receptors and the role of D-region
encoded protein in maintenance of the NAR fold; 3) a continued analysis of
somatic mutation and potential "oligonucleotide capture" in the joining
regions; 4) to study the function of NAR to determine whether T-dependent
affinity maturation occurs after immunization, and to examine the
significance of the somatic mutation; and 5) to search for NAR's presence
in diverse vertebrates to further evaluate its structure/function. It is
likely that NAR will be the first characterized novel antigen recognition
molecule in a long line awaiting discovery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evolution of Adaptive Immunity
-
批准号:10376815
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2013
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:9760130
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2013
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:9899205
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2013
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:8578698
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2013
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:8697164
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2013
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:8848970
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2013
-
负责人:Martin F Flajnik
-
依托单位:
Ontogeny and Phylogeny of the MHC
-
批准号:7921769
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2009
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:7892029
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2009
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:7893971
-
项目类别:
-
资助金额:$7.07万
-
财政年份:2009
-
负责人:Martin F Flajnik
-
依托单位:
Highly Stable, Anthrax-specific Shark Antibody Fragment
-
批准号:6771109
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2003
-
负责人:Martin F Flajnik
-
依托单位:
Highly Stable, Anthrax-specific Shark Antibody Fragment
-
批准号:6675141
-
项目类别:
-
资助金额:$27.53万
-
财政年份:2003
-
负责人:Martin F Flajnik
-
依托单位:
PILOT--FUNCTION OF J CHAIN AND SECRETORY TAIL IN IMMUNOGLOBULIN BIOSYNTHESIS
-
批准号:6301423
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2000
-
负责人:Martin F Flajnik
-
依托单位:
PILOT--FUNCTION OF J CHAIN AND SECRETORY TAIL IN IMMUNOGLOBULIN BIOSYNTHESIS
-
批准号:6495659
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2000
-
负责人:Martin F Flajnik
-
依托单位:
PILOT--FUNCTION OF J CHAIN AND SECRETORY TAIL IN IMMUNOGLOBULIN BIOSYNTHESIS
-
批准号:6442541
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2000
-
负责人:Martin F Flajnik
-
依托单位:
PILOT--FUNCTION OF J CHAIN AND SECRETORY TAIL IN IMMUNOGLOBULIN BIOSYNTHESIS
-
批准号:6106296
-
项目类别:
-
资助金额:$3.55万
-
财政年份:1999
-
负责人:Martin F Flajnik
-
依托单位:
PILOT--FUNCTION OF J CHAIN AND SECRETORY TAIL IN IMMUNOGLOBULIN BIOSYNTHESIS
-
批准号:6271167
-
项目类别:
-
资助金额:$3.62万
-
财政年份:1998
-
负责人:Martin F Flajnik
-
依托单位:
PILOT--FUNCTION OF J CHAIN AND SECRETORY TAIL IN IMMUNOGLOBULIN BIOSYNTHESIS
-
批准号:6239586
-
项目类别:
-
资助金额:$7.19万
-
财政年份:1997
-
负责人:Martin F Flajnik
-
依托单位:
EVOLUTION OF ADAPTIVE IMMUNITY
-
批准号:6044119
-
项目类别:
-
资助金额:$25.16万
-
财政年份:1991
-
负责人:Martin F Flajnik
-
依托单位:
EVOLUTION OF ADAPTIVE IMMUNITY
-
批准号:2791775
-
项目类别:
-
资助金额:$24.51万
-
财政年份:1991
-
负责人:Martin F Flajnik
-
依托单位:
Evolution of Adaptive Immunity
-
批准号:6437079
-
项目类别:
-
资助金额:$33.41万
-
财政年份:1991
-
负责人:Martin F Flajnik
-
依托单位:
海外基金